Clinical Trials in Ohio

Showing 6861-6880 of 15,929 trials

Clinical Evaluation of Two Daily Disposable Toric Soft Contact Lenses Over One Week of Wear

NCT05291936

This is a bilateral wear, dispensing, randomized, controlled, double-masked, 2-sequence ×2-period crossover study to evaluate ocular physiology following contact lens wear.

Ocular Physiology

Johnson & Johnson Vision Care, Inc.78 participantsStarted Mar 2022

Jacksonville, Florida, United States • Longwood, Florida, United States • Vestal, New York, United States +2 more locations

TERMINATEDPhase 232 miles

Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

NCT04048876

This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter, multinational, dose-finding study evaluating the efficacy of three treatment doses of CC-90001 compared with placebo, in Non-alcoholic Steatohepatitis (NASH) participants with Stage 2, Stage 3 liver fibrosis. This study is designed to assess response to treatment on measures of fibrosis and other efficacy parameters. It will also assess dose response and overall safety.

Non-alcoholic Fatty Liver DiseaseLiver Cirrhosis

Celgene56 participantsStarted Aug 2019

Phoenix, Arizona, United States • Phoenix, Arizona, United States • La Jolla, California, United States +139 more locations

Clinical Evaluation of Two Daily Disposable Toric Soft Contact Lenses Over One Week of Wear

Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Find Trials by Condition in Ohio

Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma

Telemonitoring to Treat Group 2 Pulmonary Hypertension

Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis

Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)

Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)

A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.

BRITEPath- Phase 2

Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation

Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Opioid Analgesic Reduction Study (OARS) - Pilot

A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer

Study of Safety & Effectiveness of PRESTIGE® LP Cervical Disc vs. Anterior Cervical Fusion in Cervical DDD

A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration

Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)

PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US

Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer

Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer

A Study Evaluating the Safety and Effectiveness of the PulseRider® Aneurysm Neck Reconstruction Device Used in Conjunction With Endovascular Coil Embolization in the Treatment of Wide-Neck Bifurcation Intracranial Aneurysm